Consensus IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
497.5 ^USD	-0.07%		+0.11%	-10.37%

May. 29	Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM
May. 14	Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	MT

Evolution of the average Target Price on IDEXX Laboratories, Inc.

Price target over the last 5 years

History of analyst recommendation changes

3b253bcba3a63c5.DnXTrhJL09ZwhZtCtVUFz2oRzTTklK59Sz44s9dfjJ0.eTKW9nlmoLgJ8_Iw8iNnlVsogF6pwNoSGFBdx5El-vxRRYHKcwiavTvNyg~2fde2d5daab73ab6fedaeb1e990663b3

Analyst Recommendations on IDEXX Laboratories, Inc.

Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	May. 14	MT
BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653	May. 02	MT
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675	May. 02	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570	May. 02	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655	May. 02	MT
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460	May. 02	MT
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating	Apr. 30	MT
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16
JPMorgan Adjusts Price Target on IDEXX Laboratories to $630 From $600, Maintains Overweight Rating	Feb. 06	MT
Morgan Stanley Lifts PT on IDEXX Laboratories to $620 From $600 After 'Impressive' Q4 2023 Upside, 'Solid' 2024 Guide; Overweight Kept	Feb. 06	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $655 From $605, Keeps Overweight Rating	Feb. 06	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $570 From $525, Keeps Hold Rating	Feb. 06	MT
Piper Sandler Downgrades IDEXX Laboratories to Neutral From Overweight, Price Target is $525	Jan. 30	MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Astrazeneca, Home Depot, Netflix...	Jan. 30
Goldman Sachs Hikes Price Target on IDEXX Laboratories to $650 From $500, Maintains Buy Rating	Jan. 17	MT
ANALYST RECOMMENDATIONS : AMD, Cloudflare, Intel, ITV, PayPal...	Jan. 16
Are rate cuts are coming early next year?	Dec. 07
ANALYST RECOMMENDATIONS : Biogen, Boeing, Chevron, Rio Tinto, Salesforce...	Dec. 07
ANALYST RECOMMENDATIONS : Best Buy, Glencore, Lowe's, Nvidia, Clorox...	Nov. 22
Piper Sandler Increases Price Target on IDEXX Laboratories to $525 From $520, Maintains Overweight Rating	Nov. 06	MT
ANALYST RECOMMENDATIONS : Amazon, Exxon Mobil, Ford, Walt Disney, PayPal...	Nov. 06
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $500 From $578, Maintains Buy Rating	Nov. 03	MT
Stifel Cuts IDEXX Laboratories' Price Target to $460 From $500, Maintains Hold Rating	23-10-30	MT
ANALYST RECOMMENDATIONS : Abrdn, Best Buy, Dollar General, Lowe's, Target...	23-10-05
Stifel Adjusts Price Target on IDEXX Laboratories to $500 From $525, Keeps Hold Rating	23-09-15	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

497.5 USD

Average target price

565.1 USD

Spread / Average Target

+13.58%

High Price Target

641 USD

Spread / Highest target

+28.84%

Low Price Target

400 USD

Spread / Lowest Target

-19.60%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IDEXX Laboratories, Inc.

Morgan Stanley
Stifel Nicolaus
Goldman Sachs
BNP Paribas Exane
Redburn Atlantic
Barclays
BofA Securities
JPMorgan Chase
Piper Sandler
Atlantic Equities
Credit Suisse
Guggenheim
J.P. Morgan Chase

Ratings for IDEXX Laboratories, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar